Supriya Lifescience Limited

Web: supriyalifescience.com NSE: SUPRIYA BSE: 543434 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

860 18(2%)

Volume

6L as on 23, Jun

Open

715

High

720

Low

708

843

VWAP

955

52 Week High

1,085

52 Week Low

546

Viand Research Rating

Quality Score

40/100

Growth Score

62/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

6,924

No. of Shares

8.05

P/E

38.72

P/B

6.73

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

17.39

ROCE

Profit Growth

Listing Date

28-Dec-21

Promoter Holding

68.3%

FII Holding

6.18%

DII Holding

5.3%

Price Chart

Price Performance

1 Week1%

1 Month24%

3 Months74%

6 Months59%

1 Year59%

YTD59%

Moving Average

5 Day SMA933

10 Day SMA944

20 Day SMA932

30 Day SMA859

50 Day SMA784

61 Day SMA750

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	985	938	965	983
Resistance 2	965	935	950	964
Resistance 1	946	931	941	944
Pivot Point	926	928	926	925
Support 1	908	924	912	906
Support 2	888	920	903	887
Support 3	869	917	888	867

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.28%	(0.01) 68.24%	(0.01) 68.24%	(0.01) 68.24%	(0.01) 68.24%	(0.01) 68.24%
FIIs	(1.01) 6.18%	(0.01) 5.16%	(-0.31) 5.19%	(-1.31) 5.46%	(-0.41) 6.78%	(0.71) 7.19%	(0.51) 6.52%	(1.11) 6.03%	(-0.41) 4.95%	(0.81) 5.37%	(-0.81) 4.56%	(-0.41) 5.35%	(0.11) 5.73%	(-0.61) 5.66%	(-0.61) 6.24%	(0.81) 6.79%	(-1.11) 5.99%	(-3.21) 7.13%	(0.01) 10.30%
DIIs	(-0.41) 5.30%	(0.71) 5.70%	(-0.21) 5.00%	(0.41) 5.22%	(0.61) 4.86%	(-0.71) 4.26%	(-0.51) 4.93%	(0.01) 5.45%	(0.21) 5.48%	(-0.11) 5.30%	(-1.81) 5.39%	(-0.41) 7.17%	(-0.11) 7.54%	(-0.21) 7.65%	(-1.01) 7.89%	(-1.51) 8.88%	(2.61) 10.33%	(-0.21) 7.73%	(0.01) 7.90%
Public	20.21%	20.83%	21.49%	21.02%	20.08%	20.25%	20.25%	20.22%	21.27%	21.04%	21.77%	19.19%	18.43%	18.43%	17.62%	16.09%	15.44%	16.90%	13.56%
No. of Shareholders	82,082	81,161	85,099	87,912	91,928	91,051	89,394	85,328	89,621	87,980	95,929	92,991	93,478	95,605	96,998	94,594	86,853	82,578	55,292

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	190	277	206	200	145	184	186	166	161	158	140	140	132	142	105	112	101	181	117	150
Sales Growth % (YoY)	30.8%	50.2%	11.2%	20.3%	-9.7%	16.4%	32.5%	18.6%	21.7%	11.2%	33.2%	24.9%	30.2%	-22%	-10.1%	-25.3%	31.7%	37.2%	45%	-
Sales Growth % (QoQ)	-31.4%	34.5%	3%	37.9%	-21.2%	-1.1%	12%	3.1%	1.9%	12.9%	-	6.1%	-7%	35.2%	-6.2%	10.9%	-44.2%	54.7%	-22%	-
Expenses	142	179	134	127	93	117	120	101	98	103	99	108	88	87	91	84	70	106	79	70
Operating Profit	47	98	72	73	52	68	66	65	63	56	41	32	44	55	14	29	31	75	38	80
OPM %	25	35	35	36	36	37	36	39	39	35	30	23	34	39	13	25	31	42	33	53
Other Income	3	3	2	3	3	3	2	3	2	2	3	2	3	2	3	3	2	4	5	1
Interest	0	0	0	0	1	0	1	0	0	1	0	0	1	1	1	1	1	1	1	1
Depreciation	9	8	7	7	6	6	5	5	5	4	4	4	4	3	3	3	3	3	3	2
Profit before tax	41	92	67	68	47	64	63	62	60	53	40	30	43	53	13	27	30	75	40	78
Tax %	41	19	26	26	27	21	25	26	25	31	26	20	33	28	25	39	16	39	1	25
Net Profit	24	74	50	50	35	50	47	46	45	37	30	24	29	38	10	17	25	46	40	58
Net Profit Growth % (QoQ)	-67.6%	48%	-	42.9%	-30%	6.4%	2.2%	2.2%	21.6%	23.3%	25%	-17.2%	-23.7%	280%	-41.2%	-32%	-45.7%	15%	-31%	-
Net Profit Growth % (YoY)	-31.4%	48%	6.4%	8.7%	-22.2%	35.1%	56.7%	91.7%	55.2%	-2.6%	200%	41.2%	16%	-17.4%	-75%	-70.7%	-	-	-	-
TTM Net Profit	198	209	185	182	178	188	175	158	136	120	121	101	94	90	98	128	169	144	98	0
EPS in Rs	2.99	9.22	6.17	6.27	4.32	6.26	5.81	5.73	5.55	4.59	3.7	2.97	3.54	4.75	1.18	2.09	3.14	5.74	4.93	7.96

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Sales	828	696	570	461	530	391	312	278	213	184
Sales Growth %	18.9%	22.1%	23.7%	-13%	35.5%	25.5%	12.2%	30.5%	15.9%	-
Expenses	534	436	394	332	316	218	213	213	191	166
Operating Profit	294	261	176	129	214	173	98	65	22	17
OPM %	36	37	31	28	40	44	32	23	10	9
Other Income	11	10	11	9	8	5	11	8	9	7
Interest	2	2	5	3	4	4	7	10	11	12
Depreciation	28	20	16	12	10	7	6	5	5	5
Profit before tax	275	248	166	123	207	167	96	57	14	8
Tax %	24	24	28	27	27	26	24	31	40	30
Net Profit	209	188	119	90	152	124	73	39	9	6
Net Profit Growth %	11.2%	58%	32.2%	-40.8%	22.6%	69.9%	87.2%	333.3%	50%	-
EPS in Rs	25.98	23.35	14.8	11.17	18.86	16.89	50.11	26.93	5.96	3.87
Dividend Payout %	4	4	5	5	3	3	20	0	0	0

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash from Operating Activity	165	113	64	49	76	117	49	28	27
Cash from Investing Activity	-152	-174	-124	-60	-47	-25	5	-5	-27
Cash from Financing Activity	-8	-22	-10	150	-15	-29	-50	-20	-2
Net Cash Flow	4	-83	-70	139	15	62	4	3	-2

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Equity Capital	16	16	16	16	16	16	16	15	15	15	15	15
Reserves	1182	1066	981	890	799	683	600	254	134	79	40	31
Borrowings	5	5	5	6	5	22	27	72	82	90	130	140
Other Liabilities	154	116	110	101	101	98	92	105	105	69	60	55
Total Liabilities	1357	1203	1112	1012	921	820	735	445	336	253	245	241
Fixed Assets	689	458	453	308	310	262	190	100	99	85	91	89
CWIP	36	172	148	218	149	68	43	79	40	35	34	36
Investments	99	57	63	72	64	25	0	0	0	0	0	0
Other Assets	534	516	448	415	399	466	502	267	197	133	120	117
Total Assets	1357	1203	1112	1012	921	820	735	445	336	253	245	241

Delivery

Delivery Data: SUPRIYA

#	Date	740 41% 1043	Value (Cr)	Q/T 22	Del 42	Del 35
1	4-Sep	853	28	14	48	13
2	3-Sep	843	16	16	46	8
3	2-Sep	841	80	24	26	21
4	1-Sep	803	8	13	52	4
5	31-Aug	798	14	14	49	7
6	28-Aug	804	18	17	40	7
7	27-Aug	776	8	15	47	4
8	26-Aug	782	16	22	58	9
9	25-Aug	792	9	15	45	4
10	24-Aug	797	7	15	50	4
11	21-Aug	805	10	19	45	5
12	20-Aug	812	25	19	38	9
13	19-Aug	788	11	15	54	6
14	18-Aug	802	31	22	40	13
15	17-Aug	784	33	19	52	17
16	14-Aug	792	133	26	31	41
17	13-Aug	814	43	22	41	18
18	12-Aug	831	23	19	45	10
19	11-Aug	851	79	21	40	31
20	10-Aug	923	22	15	53	12
21	7-Aug	923	21	16	46	10
22	6-Aug	891	43	19	41	18
23	5-Aug	914	25	22	55	14
24	4-Aug	888	17	18	50	8
25	3-Aug	880	22	19	53	12
26	31-Jul	867	15	16	50	7
27	30-Jul	860	14	12	44	6
28	29-Jul	860	15	15	52	8
29	28-Jul	830	8	15	44	3
30	27-Jul	845	11	14	47	5
31	24-Jul	840	9	14	44	4
32	23-Jul	833	11	15	41	4
33	22-Jul	840	17	17	47	8
34	21-Jul	864	21	13	41	9
35	20-Jul	837	9	14	49	4
36	17-Jul	829	22	19	43	9
37	16-Jul	851	11	16	35	4
38	15-Jul	852	10	18	45	5
39	14-Jul	871	30	21	35	10
40	13-Jul	845	19	18	51	10
41	10-Jul	855	21	18	47	10
42	9-Jul	875	30	21	37	11
43	8-Jul	862	58	28	31	18
44	7-Jul	842	85	27	42	36
45	6-Jul	865	215	31	31	66
46	3-Jul	979	19	17	45	9
47	2-Jul	995	34	17	35	12
48	1-Jul	1009	31	17	39	12
49	30-Jun	1018	112	24	34	39
50	29-Jun	971	36	20	45	16

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	6,924c	147c	2.17
03-Sep	6,777c	277c	4.25
01-Sep	6,500c	67c	1.04
31-Aug	6,433c	176c	2.81
27-Aug	6,258c	63c	0.99
26-Aug	6,320c	46c	0.72
25-Aug	6,366c	63c	0.98
24-Aug	6,429c	38c	0.58
21-Aug	6,467c	125c	1.97
19-Aug	6,342c	124c	1.92
18-Aug	6,466c	169c	2.68
17-Aug	6,297c	61c	0.96
14-Aug	6,359c	388c	5.74
13-Aug	6,746c	58c	0.87
12-Aug	6,688c	782c	10.47
11-Aug	7,470c	0	0
10-Aug	7,470c	204c	2.81
06-Aug	7,266c	207c	2.93
05-Aug	7,060c	94c	1.35
31-Jul	6,966c	12c	0.17
30-Jul	6,978c	80c	1.16
29-Jul	6,898c	226c	3.39
28-Jul	6,672c	125c	1.84
27-Jul	6,797c	36c	0.54
24-Jul	6,761c	0	0

Stock Checklist

Price is above from 52 week high low average: 58%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 30 fund scheme(s) across 10 fund house(s) as of Aug26 · Total value ₹183 Cr · 6 increasing / 12 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Abakkus Mutual Fund	2	0.73%	-0.21%	93.2
ITI Mutual Fund	6	1.48%	-0.27%	43
Quantum Mutual Fund	2	3.64%	-0.83%	18.5
Motilal Oswal Mutual Fund	4	0.24%	+0.02%	11.8
WhiteOak Capital Mutual Fund	2	0.82%	-0.14%	11.5
Samco Mutual Fund	2	1.50%	-	4.5
Angel One Mutual Fund	4	0.06%	+0.12%	0.1
Bandhan Mutual Fund	4	0.06%	+0.03%	0.1
Groww Mutual Fund	2	0.01%	-	0.1
Mirae Asset Mutual Fund	2	0.02%	-	0

Supriya Lifescience Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements